DC
ZBH icon

Davenport & Co’s Zimmer Biomet ZBH Stock Holding History

Davenport & Co’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$569K Sell
6,604
-1,364
-17% -$120K ﹤0.01% 963
2026
Q1 		$721K Sell
7,968
-28,924
-78% -$2.65M ﹤0.01% 807
2025
Q4 		$3.34M Sell
36,892
-3,099
-8% -$294K 0.02% 417
2025
Q3 		$3.93M Sell
39,991
-117
-0.3% -$11.6K 0.02% 387
2025
Q2 		$3.67M Buy
40,108
+1,155
+3% +$112K 0.02% 381
2025
Q1 		$4.38M Buy
38,953
+3,893
+11% +$416K 0.03% 328
2024
Q4 		$3.7M Buy
35,060
+2,227
+7% +$239K 0.02% 351
2024
Q3 		$3.55M Buy
32,833
+2,374
+8% +$259K 0.02% 351
2024
Q2 		$3.3M Buy
30,459
+7,360
+32% +$868K 0.02% 361
2024
Q1 		$3.06M Buy
23,099
+6,848
+42% +$855K 0.02% 373
2023
Q4 		$1.98M Buy
16,251
+10,166
+167% +$1.13M 0.01% 419
2023
Q3 		$683K Buy
6,085
+428
+8% +$54.4K 0.01% 643
2023
Q2 		$824K Buy
5,657
+1,200
+27% +$163K 0.01% 608
2023
Q1 		$576K Buy
4,457
+978
+28% +$123K ﹤0.01% 683
2022
Q4 		$444K Sell
3,479
-316
-8% -$36.7K ﹤0.01% 732
2022
Q3 		$397K Buy
3,795
+106
+3% +$11.6K ﹤0.01% 745
2022
Q2 		$388K Sell
3,689
-176
-5% -$20.9K ﹤0.01% 744
2022
Q1 		$494K Sell
3,865
-45
-1% -$5.42K ﹤0.01% 737
2021
Q4 		$482K Sell
3,910
-1,290
-25% -$169K ﹤0.01% 765
2021
Q3 		$739K Buy
5,200
+1,569
+43% +$231K 0.01% 616
2021
Q2 		$567K Buy
3,631
+482
+15% +$78.1K ﹤0.01% 615
2021
Q1 		$489K Buy
+3,149
New +$488K ﹤0.01% 539
2014
Q3 		– Sell
-2,496
Closed -$252K – 620
2014
Q2 		$252K Hold
2,496
– – ﹤0.01% 507
2014
Q1 		$229K Sell
2,496
-164
-6% -$15.1K ﹤0.01% 516
2013
Q4 		$241K Sell
2,660
-103
-4% -$8.91K ﹤0.01% 490
2013
Q3 		$220K Sell
2,763
-384
-12% -$30.2K ﹤0.01% 483
2013
Q2 		$229K Buy
+3,147
New +$235K 0.01% 454

Other funds holding ZBH

DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return
WAM
Wilsey Asset Management San Diego, California $681M AUM 6.7% 1-Year Est. Return
QAM
QSM Asset Management London, United Kingdom $193M AUM 47.49% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
NCM
Northside Capital Management Hood River, Oregon $1.22B AUM 20.77% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
SFA
Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return
GHAM
Gilman Hill Asset Management New Canaan, Connecticut $731M AUM 19.41% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Davenport & Co's ZBH Position: Q2 2026 in Review

Davenport & Co reduced its Zimmer Biomet (ZBH) stake by 17% in Q2 2026, selling an estimated $120K and leaving 6,604 shares worth $569K. The position accounts for ﹤0.01% of the portfolio, ranked #963.

Davenport & Co first reported a position in ZBH in Q2 2013 and has held it in 27 quarters since. The position peaked at $4.38M in Q1 2025. 132 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

  • Davenport & Co held 6,604 shares of Zimmer Biomet worth $569K as of Q2 2026.
  • Davenport & Co sold 1,364 Zimmer Biomet shares in Q2 2026, an estimated $120K.
  • Zimmer Biomet made up ﹤0.01% of Davenport & Co's portfolio in Q2 2026, its #963 holding.
  • Davenport & Co first reported a position in Zimmer Biomet in Q2 2013 and has held it in 27 quarters since.
  • Davenport & Co's Zimmer Biomet position peaked at $4.38M in Q1 2025.
  • 132 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Davenport & Co's 13F filing for Q2 2026, filed 13 Jul 2026.